United States of America

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
0.38 (0.29 - 0.49)	1994	Survey/reported	Wasley A et al, 2010
0.27 (0.20 - 0.35)	2006	Survey/reported	Wasley A et al, 2010
0.3 (0.20 - 0.40)	2012	Survey/reported	Roberts H et al, 2016
0.23 (0.18 - 0.28)	2015	Modelled	WHO
0.3 (0.20 - 0.30)	2016	Modelled	Razavi-Shearer et al, 2018
0.27 (0.24 - 0.30)	2013	Modelled	Schweitzer et al, 2015
0.34 (0.30 - 0.38)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
0.37 (0.32 - 0.42)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
0.37 (0.33 - 0.42)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
0.38 (0.34 - 0.43)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
0.4 (0.35 - 0.44)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
0.4 (0.35 - 0.45)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
0.41 (0.36 - 0.46)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
0.42 (0.37 - 0.47)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
0.43 (0.38 - 0.48)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
0.44 (0.39 - 0.49)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
0.44 (0.39 - 0.50)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
0.46 (0.40 - 0.51)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
0.47 (0.41 - 0.53)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
0.48 (0.42 - 0.54)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
0.49 (0.43 - 0.55)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
0.49 (0.43 - 0.56)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
0.5 (0.44 - 0.56)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
0.51 (0.44 - 0.57)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
0.51 (0.45 - 0.57)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
0.51 (0.45 - 0.58)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
0.52 (0.45 - 0.58)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
0.53 (0.46 - 0.59)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
0.54 (0.47 - 0.60)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.47 - 0.61)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.48 - 0.62)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.48 - 0.62)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
0.55 (0.48 - 0.63)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
0.56 (0.48 - 0.63)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
0.56 (0.49 - 0.64)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
0.57 (0.49 - 0.64)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
0.37 (0.32 - 0.41)	2019	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.04 (0.03 - 0.05)	2015	Modelled	WHO
0.03 (0.02 - 0.04)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
0.05 (0.03 - 0.06)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.10)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.11)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.12)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
0.11 (0.08 - 0.14)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.17)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
0.16 (0.12 - 0.20)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
0.19 (0.14 - 0.24)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
0.01 (0.01 - 0.02)	2020	Modelled	WHO

Showing out of

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
875,000 (654,000 - 1,033,000)	2016	Modelled	Razavi-Shearer et al, 2018
862,000	2016	Survey/reported	Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR
2,400,000	2016	Survey/reported	Wong, R.J. et al
1,108,930 (968,729 - 1,253,410)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
1,139,350 (995,333 - 1,285,450)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
1,138,660 (996,177 - 1,285,030)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
1,140,310 (997,996 - 1,283,890)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
1,172,620 (1,028,550 - 1,312,930)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
1,203,950 (1,054,600 - 1,344,410)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
1,210,520 (1,062,790 - 1,352,820)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
1,226,200 (1,079,990 - 1,370,680)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
1,244,380 (1,098,100 - 1,392,220)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
1,258,920 (1,109,190 - 1,409,830)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
1,264,050 (1,115,330 - 1,417,690)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
1,273,340 (1,122,470 - 1,428,880)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
1,297,110 (1,141,020 - 1,456,370)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1,324,450 (1,161,580 - 1,485,660)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1,345,230 (1,176,000 - 1,511,760)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1,350,000 (1,178,460 - 1,518,630)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1,347,300 (1,177,160 - 1,513,260)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1,349,680 (1,179,240 - 1,513,010)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
1,353,220 (1,184,700 - 1,516,250)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
1,354,100 (1,184,790 - 1,516,640)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1,348,870 (1,181,620 - 1,516,390)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
1,347,200 (1,179,820 - 1,512,460)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
1,356,070 (1,183,340 - 1,523,440)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
1,367,970 (1,193,370 - 1,534,730)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
1,375,870 (1,198,600 - 1,544,970)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
1,373,270 (1,193,270 - 1,544,810)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
1,365,560 (1,187,140 - 1,536,170)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
1,361,670 (1,182,960 - 1,536,740)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
1,360,050 (1,181,530 - 1,541,050)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
1,359,260 (1,179,500 - 1,545,610)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
1,358,120 (1,178,630 - 1,545,100)	1990	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Number of new cases of HBV

National

Download

Value	Year	Type	Source
20,700 (11,800 - 50,800)	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
0.5	2014	Survey/reported	US CDC
0.45	2016	Survey/reported	US CDC
0.46	2017	Survey/reported	US CDC
0.52	2010	Survey/reported	US CDC
0.51	2011	Survey/reported	US CDC
0.51	2012	Survey/reported	US CDC
0.53	2013	Survey/reported	US CDC
0.46	2015	Survey/reported	US CDC
0.42	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B
1.37 (1.18 - 1.58)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
0.98 (0.88 - 1.10)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
0.97 (0.87 - 1.06)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
0.96 (0.86 - 1.05)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
0.97 (0.88 - 1.06)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
0.99 (0.90 - 1.07)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
0.97 (0.89 - 1.06)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
1 (0.91 - 1.08)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
1.01 (0.92 - 1.10)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
1.03 (0.95 - 1.12)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
1.06 (0.97 - 1.15)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
1.08 (0.99 - 1.18)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
1.12 (1.02 - 1.22)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
1.1 (1.01 - 1.20)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1.13 (1.03 - 1.23)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
1.13 (1.03 - 1.23)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1.16 (1.06 - 1.26)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1.18 (1.08 - 1.28)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (1.08 - 1.29)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1.2 (1.10 - 1.32)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1.22 (1.11 - 1.34)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
1.24 (1.12 - 1.36)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
1.27 (1.15 - 1.40)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
1.31 (1.18 - 1.45)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
1.35 (1.22 - 1.50)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
1.39 (1.25 - 1.54)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
1.4 (1.25 - 1.57)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
1.34 (1.17 - 1.52)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
1.43 (1.28 - 1.59)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
1.36 (1.18 - 1.55)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
1.37 (1.18 - 1.58)	2019	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
11,522	2016	Modelled	WHO
1,662	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B
2,498 (2,240 - 2,778)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
2,475 (2,228 - 2,727)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
2,479 (2,241 - 2,724)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
2,576 (2,351 - 2,803)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
2,639 (2,413 - 2,869)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
2,533 (2,299 - 2,770)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
2,688 (2,461 - 2,917)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
2,752 (2,520 - 2,989)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
2,845 (2,611 - 3,087)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
2,947 (2,705 - 3,193)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
3,041 (2,791 - 3,302)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
3,196 (2,930 - 3,479)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
3,120 (2,858 - 3,393)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
3,262 (2,985 - 3,558)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
3,292 (3,017 - 3,587)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
3,408 (3,118 - 3,714)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
3,498 (3,202 - 3,815)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
3,569 (3,252 - 3,893)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
3,739 (3,397 - 4,099)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
3,654 (3,327 - 4,001)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
3,965 (3,595 - 4,371)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
3,817 (3,459 - 4,201)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
4,108 (3,718 - 4,542)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
4,261 (3,856 - 4,728)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
4,516 (4,023 - 5,073)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
4,584 (4,107 - 5,100)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
4,423 (3,984 - 4,917)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
4,345 (3,813 - 4,935)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
4,422 (3,862 - 5,064)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
4,486 (3,874 - 5,178)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
4,486 (3,874 - 5,178)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
4 (3 - 5)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
4 (4 - 5)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
4 (4 - 5)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
4 (4 - 5)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
4 (4 - 5)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4 - 5)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4 - 5)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
5 (4 - 6)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
5 (5 - 6)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
6 (5 - 6)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
6 (5 - 6)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
6 (6 - 7)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
6 (5 - 7)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
6 (6 - 7)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
7 (6 - 8)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
7 (6 - 8)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
7 (7 - 8)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
8 (7 - 9)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
8 (7 - 9)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
8 (7 - 9)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
9 (7 - 10)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
8 (7 - 10)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 10)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 10)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 10)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 11)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 11)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 11)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 11)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8 - 11)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
12 (10 - 14)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Coverage of HepB birth dose

Newborns

Download

Value (%)	Year	Type	Source
67	2019	Survey/reported	WHO/UNICEF
66	2018	Survey/reported	WHO/UNICEF
64	2017	Survey/reported	WHO/UNICEF
64	2016	Survey/reported	WHO/UNICEF
72	2015	Survey/reported	WHO/UNICEF
72	2014	Survey/reported	WHO/UNICEF
74	2013	Survey/reported	WHO/UNICEF
72	2012	Survey/reported	WHO/UNICEF
69	2011	Survey/reported	WHO/UNICEF
64	2010	Survey/reported	WHO/UNICEF
61	2009	Survey/reported	WHO/UNICEF
55	2008	Survey/reported	WHO/UNICEF
53	2007	Survey/reported	WHO/UNICEF
50	2006	Survey/reported	WHO/UNICEF
50	2005	Survey/reported	WHO/UNICEF
48	2004	Survey/reported	WHO/UNICEF
39	2003	Survey/reported	WHO/UNICEF
21	2002	Survey/reported	WHO/UNICEF
69	2020	Survey/reported	WHO/UNICEF
76	2017	Survey/reported	Hill HA et al, 2020
69	2021	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
91	2019	Survey/reported	WHO/UNICEF
91	2020	Survey/reported	WHO/UNICEF
91	2017	Survey/reported	Hill HA et al, 2020
91	2021	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Proportion of persons living with HBV diagnosed

National

Download

Value (%)	Year	Type	Source
32	2016	Survey/reported	U.S. Department of Health and Human Services

Proportion of diagnosed HBV persons receiving appropriate treatment

National

Download

Value (%)	Year	Type	Source
18	2016	Survey/reported	Harris AM et al, 2020

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
30 (11 - 49)	2016	Survey/reported	NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013

Technical notes

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Toy M et al

System for monitoring testing and treatment

Partially Adopted

Harris, A.M. et al

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

1999

Source: WHO

Recommendations for HBV testing of pregnant women

Adopted

U.S. Department of Health and Human Services

Eligible for HBV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HBV

Not Adopted

HBV testing policy

Pregnant women, Risk-based

Source:

HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)

Adopted

US CDC

No patient co-pays for HBsAg testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

Terrault, N. A et al

Simplified care: No treatment co-pays

Partially Adopted

Adult HBV vaccination policy for high-risk populations

Adopted

Schillie, S et al

Public budget line for testing and treatment

Adopted

US CDC

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Roebuck MC, Liberman JN

System for monitoring testing and treatment

Partially Adopted

Isenhour C et al

Recommendations for HCV testing of pregnant women

Adopted

US CDC

Registration of originator HCV DAAs

Adopted

US Food and Drug Administration

Eligible for HCV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HCV

Not Adopted

HCV testing policy

Universal

Source:

No patient co-pays for anti-HCV testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

AASLD-IDSA

Simplified care: Non-specialists can prescribe treatment

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

Simplified care: No treatment co-pays

Partially Adopted

No fibrosis restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

No sobriety restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

National policy for harm reduction for persons who inject drugs

Adopted

Georgetown HIV Policy Lab

National policy for syringe exchange in federal prisons

Not Adopted

Georgetown HIV Policy Lab

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Many (31-60%)

Source: WHO

Decriminalization of possession of syringes and paraphernalia

Partially Adopted

Public budget line for testing and treatment

Adopted

US CDC

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
1 (0.80 - 1.10)	2016	Survey/reported	Hofmeister MG et al, 2019 (Adjusted)
1 (0.80 - 1.20)	2010	Survey/reported	Denniston MM et al, 2014 (Unadjusted)
1.3 (1 - 1.50)	2002	Survey/reported	Armstrong GL wt al, 2006 (Unadjusted)
0.9 (0.70 - 1.20)	2015	Modelled	Blach et al, 2017
0.84 (0.75 - 0.96)	2016	Survey/reported	Rosenberg et al, 2018 (Unadjusted)
0.93	2016	Survey/reported	Rosenberg et al, 2018 (Adjusted)
1 (0.90 - 1.80)	2014	Modelled	Gower et al, 2014
1.25 (1.02 - 1.54)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
1.26 (1.02 - 1.55)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
1.26 (1.02 - 1.54)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
1.23 (1 - 1.51)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
1.2 (0.98 - 1.47)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (0.97 - 1.46)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (0.97 - 1.46)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (0.97 - 1.46)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (0.96 - 1.46)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (0.96 - 1.46)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (0.96 - 1.47)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
1.2 (0.97 - 1.48)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
1.22 (0.98 - 1.50)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
1.23 (0.99 - 1.52)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
1.24 (1 - 1.53)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
1.24 (1 - 1.53)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
1.24 (0.99 - 1.53)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
1.24 (0.99 - 1.53)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
1.23 (0.99 - 1.53)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
1.23 (0.98 - 1.52)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
1.21 (0.97 - 1.50)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
1.19 (0.95 - 1.47)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
1.16 (0.93 - 1.44)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
1.13 (0.91 - 1.41)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
1.12 (0.90 - 1.39)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
1.1 (0.88 - 1.37)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
1.09 (0.87 - 1.36)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
1.08 (0.87 - 1.34)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
1.06 (0.85 - 1.32)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
1.05 (0.84 - 1.31)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
1.18 (0.95 - 1.45)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Women of childbearing age (15–49 years)

Download

Value (%)	Year	Type	Source
0.49 (0.37 - 0.64)	2019	Modelled	Dugan et al., 2021

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
1.7 (1.40 - 2)	2016	Survey/reported	Hofmeister MG et al, 2019 (Adjusted)
1.3 (1.20 - 1.50)	2010	Survey/reported	Denniston MM et al, 2014 (Unadjusted)
1.6 (1.30 - 1.90)	2002	Survey/reported	Armstrong GL wt al, 2006 (Unadjusted)
1.8 (1.50 - 2.30)	1994	Survey/reported	Alter MJ et al, 1999 (Unadjusted)
1.9 (1.50 - 2.50)	2002	Survey/reported	Ditah et al, 2014
1.3 (0.90 - 1.80)	2006	Survey/reported	Ditah et al, 2014
1.48	2019	Modelled	Jin et al. 2017
1.3 (1.20 - 2.40)	2014	Modelled	Gower et al, 2014

Showing out of

Men who have sex with men (MSM) Living with HIV

Download

Value (%)	Year	Type	Source
9.7 (7.10 - 12.60)	2019	Modelled	Jin et al. 2017

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
53.1 (38.10 - 68)	2016	Modelled	Degenhardt L et al, 2017

Men who have sex with men (MSM)

Download

Value (%)	Year	Type	Source
4.4	2019	Modelled	Jin et al. 2017

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
2,936,000 (2,231,000 - 3,826,000)	2015	Modelled	Blach et al, 2017
2,400,000	2016	Survey/reported	US CDC
2,519,250 (2,019,580 - 3,149,250)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
2,567,040 (2,059,080 - 3,206,460)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
2,620,180 (2,107,400 - 3,268,480)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
2,676,400 (2,154,060 - 3,340,820)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
2,732,710 (2,198,420 - 3,399,680)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
2,789,860 (2,248,100 - 3,464,760)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
2,860,910 (2,305,140 - 3,551,960)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
2,954,980 (2,380,770 - 3,673,490)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
3,056,730 (2,463,570 - 3,801,140)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
3,148,740 (2,535,630 - 3,911,860)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
3,216,480 (2,589,140 - 3,993,100)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
3,261,100 (2,626,960 - 4,034,700)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
3,300,340 (2,660,860 - 4,078,900)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
3,335,740 (2,690,850 - 4,127,690)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
3,367,660 (2,721,080 - 4,172,570)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
3,398,480 (2,749,450 - 4,216,270)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
3,414,710 (2,765,800 - 4,236,680)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
3,414,940 (2,768,060 - 4,229,390)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
3,410,470 (2,766,150 - 4,215,210)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
3,411,690 (2,770,420 - 4,208,510)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
3,432,700 (2,793,440 - 4,225,520)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
3,466,620 (2,819,040 - 4,264,040)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
3,502,940 (2,851,980 - 4,303,690)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
3,542,590 (2,884,740 - 4,345,020)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
3,585,500 (2,921,770 - 4,393,670)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
3,634,680 (2,947,680 - 4,451,870)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
3,749,680 (3,048,880 - 4,594,180)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
3,864,380 (3,141,540 - 4,732,270)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
3,899,850 (3,171,200 - 4,776,430)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
3,900,550 (3,170,570 - 4,781,980)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
3,865,100 (3,131,620 - 4,746,640)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Women of childbearing age (15–49 years)

Download

Value	Year	Type	Source
368,000 (280,000 - 480,000)	2019	Modelled	Dugan et al., 2021

Number of new cases of HCV

National

Download

Value	Year	Type	Source
57,500 (45,500 - 196,000)	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C

Rate of new HCV cases

American Indian/Alaska Native

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
3.6	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
3.6	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
2.9	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
3.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.7	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.3	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
1.7	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
2	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
1.08	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.5	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.46	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.5	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

Asian/Pacific Islander

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.2	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.2	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.1	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.1	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.1	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.05	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.04	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.04	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

Black, non-Hispanic

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.7	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.6	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.5	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.3	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.3	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.2	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.2	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.2	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.14	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.12	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.1	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.2	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

Hispanic

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.6	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.5	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.4	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.4	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.3	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.2	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.2	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.2	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.17	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.16	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.1	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.1	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

White, non-Hispanic

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
1.4	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
1.3	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
1.2	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
1.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.9	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.8	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.8	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.6	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.47	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.32	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.3	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009
0.3	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Showing out of

0-19 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.1	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.1	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.1	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.1	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.1	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.11	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.1	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

Less than 15 years old

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

20-29 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
2.9	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
3.1	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
2.8	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
2.7	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
2.4	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
2.2	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
2	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
1.73	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
1.18	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.8	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.7	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

25-39 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.5	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

30-39 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
3.2	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
2.6	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
2.3	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
2.2	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.7	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
1.7	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
1.3	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
1.1	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.8	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.6	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.5	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

15-24 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.4	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

50-59 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
1.1	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.9	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.8	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.6	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.6	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.4	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.5	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.4	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.3	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.3	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.3	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

40-49 year olds

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
1.7	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
1.3	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
1.1	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
1.2	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.9	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.7	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.7	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.6	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.5	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0.4	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.5	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

Over 40 years old

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.3	2008	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2008

Over 60 years old

Download

Value (Number of new cases per 100,000 persons)	Year	Type	Source
0.5	2019	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2019
0.4	2018	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2018
0.3	2017	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2017
0.2	2016	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2015	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2016
0.1	2014	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2014
0.1	2013	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2013
0.1	2012	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2012
0.07	2011	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2011
0	2010	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2010
0.04	2009	Survey/reported	US CDC. Viral Hepatitis Surveillance Report 2009

Showing out of

Technical notes

HCV-related death rate

National

Download

Value (Deaths per 100,000)	Year	Type	Source
4.45	2016	Survey/reported	US CDC, 2016
4.91	2015	Survey/reported	US CDC, 2020
5.01	2014	Survey/reported	US CDC, 2019
5.03	2013	Survey/reported	US CDC, 2018
4.96	2012	Survey/reported	US CDC, 2017
3.33	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C
11.9 (10.80 - 13.10)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
6.68 (6.07 - 7.37)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
6.8 (6.24 - 7.43)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
6.95 (6.41 - 7.53)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
7.23 (6.70 - 7.80)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
7.4 (6.87 - 7.95)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
7.56 (7.03 - 8.13)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
7.63 (7.10 - 8.20)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
7.75 (7.23 - 8.33)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
7.94 (7.39 - 8.53)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
8.17 (7.63 - 8.78)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
8.4 (7.87 - 9.01)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
8.84 (8.27 - 9.48)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
8.62 (8.08 - 9.25)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
9 (8.41 - 9.66)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
9.01 (8.41 - 9.68)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
9.24 (8.62 - 9.95)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
9.4 (8.76 - 10.12)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
9.54 (8.88 - 10.27)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
9.77 (9.09 - 10.54)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
10.14 (9.40 - 10.92)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
9.99 (9.28 - 10.78)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
10.44 (9.69 - 11.24)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
10.67 (9.88 - 11.51)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
10.89 (10.09 - 11.78)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
11.14 (10.32 - 12.07)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
11.4 (10.55 - 12.37)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
11.73 (10.77 - 12.76)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
11.72 (10.61 - 12.91)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
11.85 (10.73 - 13.07)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
11.94 (10.83 - 13.15)	2019	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
21,698	2016	Modelled	WHO
14,242	2019	Survey/reported	US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C
39,158 (35,520 - 43,124)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
39,158 (35,520 - 43,124)	2019	Modelled	IHME, GBD 2019 (accessed 2020)
38,668 (35,028 - 42,654)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
38,054 (34,421 - 41,900)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
37,842 (34,759 - 41,187)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
36,565 (33,841 - 39,660)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
35,460 (32,872 - 38,434)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
34,425 (31,893 - 37,241)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
33,475 (31,022 - 36,115)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
32,530 (30,185 - 35,022)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
31,333 (29,056 - 33,738)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
30,611 (28,418 - 33,016)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
29,671 (27,590 - 31,990)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
28,701 (26,694 - 30,881)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
27,985 (26,076 - 30,138)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
27,242 (25,403 - 29,330)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
26,287 (24,541 - 28,240)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
26,004 (24,309 - 27,918)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
25,293 (23,674 - 27,122)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
24,439 (22,913 - 26,212)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
23,578 (22,096 - 25,300)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
22,700 (21,193 - 24,409)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
21,850 (20,334 - 23,461)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
21,121 (19,696 - 22,687)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
20,584 (19,155 - 22,118)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
20,201 (18,781 - 21,711)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
19,577 (18,175 - 21,045)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
18,940 (17,555 - 20,435)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
18,010 (16,624 - 19,510)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
17,433 (16,011 - 19,047)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
16,950 (15,387 - 18,693)	1990	Modelled	IHME, GBD 2019 (accessed 2022)

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
11 (10 - 13)	1990	Modelled	IHME, GBD 2019 (accessed 2022)
12 (11 - 13)	1991	Modelled	IHME, GBD 2019 (accessed 2022)
12 (11 - 14)	1992	Modelled	IHME, GBD 2019 (accessed 2022)
14 (13 - 15)	1995	Modelled	IHME, GBD 2019 (accessed 2022)
13 (12 - 15)	1994	Modelled	IHME, GBD 2019 (accessed 2022)
13 (12 - 14)	1993	Modelled	IHME, GBD 2019 (accessed 2022)
15 (13 - 16)	1996	Modelled	IHME, GBD 2019 (accessed 2022)
15 (14 - 17)	1997	Modelled	IHME, GBD 2019 (accessed 2022)
16 (15 - 18)	1998	Modelled	IHME, GBD 2019 (accessed 2022)
17 (15 - 18)	1999	Modelled	IHME, GBD 2019 (accessed 2022)
18 (16 - 19)	2000	Modelled	IHME, GBD 2019 (accessed 2022)
18 (16 - 20)	2001	Modelled	IHME, GBD 2019 (accessed 2022)
19 (17 - 20)	2002	Modelled	IHME, GBD 2019 (accessed 2022)
21 (19 - 22)	2004	Modelled	IHME, GBD 2019 (accessed 2022)
20 (18 - 21)	2003	Modelled	IHME, GBD 2019 (accessed 2022)
22 (20 - 23)	2005	Modelled	IHME, GBD 2019 (accessed 2022)
23 (21 - 25)	2006	Modelled	IHME, GBD 2019 (accessed 2022)
25 (23 - 27)	2008	Modelled	IHME, GBD 2019 (accessed 2022)
26 (24 - 28)	2009	Modelled	IHME, GBD 2019 (accessed 2022)
24 (22 - 26)	2007	Modelled	IHME, GBD 2019 (accessed 2022)
27 (25 - 30)	2010	Modelled	IHME, GBD 2019 (accessed 2022)
28 (25 - 31)	2011	Modelled	IHME, GBD 2019 (accessed 2022)
29 (26 - 31)	2012	Modelled	IHME, GBD 2019 (accessed 2022)
29 (26 - 32)	2013	Modelled	IHME, GBD 2019 (accessed 2022)
30 (27 - 33)	2014	Modelled	IHME, GBD 2019 (accessed 2022)
31 (28 - 34)	2016	Modelled	IHME, GBD 2019 (accessed 2022)
31 (27 - 34)	2017	Modelled	IHME, GBD 2019 (accessed 2022)
31 (28 - 34)	2015	Modelled	IHME, GBD 2019 (accessed 2022)
31 (27 - 35)	2018	Modelled	IHME, GBD 2019 (accessed 2022)
31 (27 - 36)	2019	Modelled	IHME, GBD 2019 (accessed 2022)
39 (35 - 43)	2019	Modelled	IHME, GBD 2019 (accessed 2020)

Showing out of

Technical notes

Number of persons initiating HCV treatment

National

Download

Value	Year	Type	Source
109,096	2014	Survey/reported	Teshale et al, 2022
164,232	2015	Survey/reported	Teshale et al, 2022
134,285	2016	Survey/reported	Teshale et al, 2022
114,419	2017	Survey/reported	Teshale et al, 2022
122,664	2018	Survey/reported	Teshale et al, 2022
114,893	2019	Survey/reported	Teshale et al, 2022
83,740	2020	Survey/reported	Teshale et al, 2022

Showing out of

Demographic breakdown of persons treated for HCV

Females (2014-2020)

Download

Value (%)	Year	Type	Source
39.2	2020	Survey/reported	Teshale et al, 2022

Males (2014-2020)

Download

Value (%)	Year	Type	Source
59.6	2020	Survey/reported	Teshale et al, 2022

Persons born after 1965

Download

Value (%)	Year	Type	Source
17.4	2014	Survey/reported	Teshale et al, 2022
51.3	2020	Survey/reported	Teshale et al, 2022

Showing out of

Persons born during 1945–1965

Download

Value (%)	Year	Type	Source
73.6	2014	Survey/reported	Teshale et al, 2022
46.3	2020	Survey/reported	Teshale et al, 2022

Showing out of

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
30 (11 - 49)	2016	Survey/reported	NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013

Technical notes

Proportion of persons living with HCV diagnosed

National

Download

Value (%)	Year	Type	Source
60	2016	Survey/reported	U.S. Department of Health and Human Services

Proportion of persons living with HCV who have cleared HCV infection

National

Download

Value (%)	Year	Type	Source
43	2016	Survey/reported	U.S. Department of Health and Human Services

HBV National Action Plan

Source:

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Toy M et al

System for monitoring testing and treatment

Partially Adopted

Harris, A.M. et al

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

1999

Source: WHO

Recommendations for HBV testing of pregnant women

Adopted

U.S. Department of Health and Human Services

Eligible for HBV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HBV

Not Adopted

HBV testing policy

Pregnant women, Risk-based

Source:

HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)

Adopted

US CDC

No patient co-pays for HBsAg testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

Terrault, N. A et al

Simplified care: No treatment co-pays

Partially Adopted

Adult HBV vaccination policy for high-risk populations

Adopted

Schillie, S et al

Public budget line for testing and treatment

Adopted

US CDC

HCV National Action Plan

Source:

HCV elimination goal

Source:

Year of HCV elimination goal

2030

Source:

National prevalence survey within the last 5 years

Adopted

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD…

Estimates of economic burden

Adopted

Roebuck MC, Liberman JN

System for monitoring testing and treatment

Partially Adopted

Isenhour C et al

Recommendations for HCV testing of pregnant women

Adopted

US CDC

Registration of originator HCV DAAs

Adopted

US Food and Drug Administration

Eligible for HCV generic medicines

Source: MPP

Licensed point-of-care PCR testing to detect HCV

Not Adopted

HCV testing policy

Universal

Source:

No patient co-pays for anti-HCV testing

Adopted

U.S Department of Health and Human Service

National treatment guidelines exist

Adopted

AASLD-IDSA

Simplified care: Non-specialists can prescribe treatment

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

Simplified care: No treatment co-pays

Partially Adopted

No fibrosis restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

No sobriety restrictions

Partially Adopted

Center for Health Law and Policy Innovation, Harvard Law School

National policy for harm reduction for persons who inject drugs

Adopted

Georgetown HIV Policy Lab

National policy for syringe exchange in federal prisons

Not Adopted

Georgetown HIV Policy Lab

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Yes

Source: Harm Reduction International

OST in at least one prison

Yes

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Many (31-60%)

Source: WHO

Decriminalization of possession of syringes and paraphernalia

Partially Adopted

Public budget line for testing and treatment

Adopted

US CDC

Overview

HBV elimination goal

Year of goal

2030

HCV elimination goal

Year of goal

2030

Prevalence (national)

Modelled

IHME, GBD 2019 (accessed 2020)

IHME, GBD 2019 (accessed 2022)

Survey/surveillance

Roberts H et al, 2016

HCV (anti-HCV)

HCV

53.10 (%)

2016, latest modelled

(38.10 - 68(%))

Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No. of syringes/PWID/year

Survey/surveillance

HCV

2016

(11 - 49)

NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013

Eligible for HBV generic medicines

Eligible for HCV generic medicines

Download National Hepatitis Elimination Profile (N-HEP)

Latest news

Coalition hosts event calling for a UN Group of Friends to support global hepatitis elimination

26 Sep 2022

View all

Action plan

United States-Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C

2010

Colvin, H.M. & Mitchell, A.E., National Academies of Medicine

View all

Elimination champion

Dr. Angela Park (2021)

We want to get to the root causes of problems that are identified...It's about how you can innovate without changing an entire system... For example, you're just changing the way you're offering testing. It doesn't cost money. It's not a big invention, it's not technological. But you can change something and have a big impact just by finding out what the root cause of a problem is.

Rachel Gonzalez (2021)

It is revolutionary what the Hepatitis C Innovation Team (HIT) did because you're talking about a federal health care system made up of more than 150 medical centers and 1000 sites of care. How do you move this giant ship? We built a community and said these goals really are aspirational, but we believe in the field teams. We believe in their ability to be creative -- to push innovation. . . If you [only] work in [a] safe space, you’ll never find many of the genuine breakthroughs that came out of HIT.

Dr. Lesley Miller (2019)

Dr. Miller built a program in an urban hospital setting treating 500 patients annually with a cure rate of 98%.

News

Coalition hosts event calling for a UN Group of Friends to support global hepatitis elimination

26 Sep 2022

New publication in Lancet Gastro Hep: "Hepatitis C in pregnancy and the TiP-HepC registry"

15 Jun 2022

CGHE Community of Practice Newsletter: May 2022

27 May 2022

Clusters of Children with Severe Acute Hepatitis Reported Globally: Is Adenovirus F- 41 the Cause?

25 Apr 2022

WHD: Coalition for Global Hepatitis Elimination and Local Partners in 30 Countries Launch National Hepatitis Elimination Profiles (N-HEP)

28 Jul 2021

Announcing the 2021 Hepatitis Elimination Champions

23 Jul 2021

May Webinar to Highlight Research to Address Disparities in Hepatitis Burden

28 Apr 2021

Inaugural North American Viral Hepatitis Elimination Summit meets from May 2 to May 5

16 Apr 2021

Action plans

United States Division of Viral Hepatitis (DVH) Strategic Plan, 2016–2020: Bringing Together Science and Public-Health Practice for the Elimination of Viral Hepatitis

2016

Division of Viral Hepatitis, Centers for Disease Control and Prevention

County of Los Angeles Adult Viral Hepatitis Prevention Plan 2010 - 2015-- California, United States

2010

Los Angeles Adult Viral Hepatitis Coalition and County of Los Angeles Department of Public Health

End Hep C SF Strategic Plan 2017-2019

2017

End Hep C SF

United States National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention- Strategic Plan through 2020

National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention

State of New Hampshire Viral Hepatitis Prevention and Control Plan--United States

2009

New Hampshire Department of Health and Human Services

Santa Clara Hepatitis B Strategic Plan 2016-2020

2016

Santa Clara County Public Health

United States-Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C

2010

Colvin, H.M. & Mitchell, A.E., National Academies of Medicine

Oklahoma Hepatitis Prevention and Control Plan 2013-2018-- United States

2013

Oklahoma State Department of Health

Oklahoma Hepatitis Prevention and Control Plan 2013-2018-- United States

2013

Oklahoma State Department of Health

Eliminating the Public Health Problem of Hepatitis B and C in the United States Phase One Report

2016

Committee on a National Strategy for the Elimination of Hepatitis, B.,Board on Population, Health,Public Health, Practice,Health,,Medicine, Division,National Academies of Sciences, Engineering,Medicine